Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

DPA-714

Copy Product Info
😃Good
Catalog No. T15162Cas No. 958233-07-3

DPA-714 is a high-affinity translocator protein (TSPO) ligand (Ki=7 nM) designed with a fluorine atom, allowing labeling with fluorine-18 for in vivo imaging via positron emission tomography. [18F]DPA-714 successfully enables specific imaging of inflammation in various neuroinflammation models and a brain tumor model.

DPA-714

DPA-714

Copy Product Info
😃Good
Purity: 99.52%
Catalog No. T15162Cas No. 958233-07-3
DPA-714 is a high-affinity translocator protein (TSPO) ligand (Ki=7 nM) designed with a fluorine atom, allowing labeling with fluorine-18 for in vivo imaging via positron emission tomography. [18F]DPA-714 successfully enables specific imaging of inflammation in various neuroinflammation models and a brain tumor model.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$47In StockIn Stock
5 mg$113In StockIn Stock
10 mg$170In StockIn Stock
25 mg$315In StockIn Stock
50 mg$457-In Stock
100 mg$648-In Stock
1 mL x 10 mM (in DMSO)$119In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.52%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

DPA-714 AI Summary
DPA-714 shows high affinity for the translocator protein (TSPO) receptor in various rat tissues, with reported Ki values ranging from 0.91 nM in rat heart membranes to 7.0 nM in rat kidney and brain cortex mitochondrial membranes. This indicates its potential bioactivity as a modulator of TSPO, a receptor involved in cellular functions such as apoptosis, inflammation, and neuroprotection. Despite its strong affinity for TSPO, DPA-714 exhibits very low affinity for the central benzodiazepine receptor (CBR), with Ki values greater than 1000.0 nM in rat cerebral cortex membranes. The compound has moderate lipophilicity, with reported LogP values from 2.12 to 2.89 at pH 7.4-7.5. Metabolic studies show that the compound is subjected to different rates of drug metabolism, with intrinsic clearance values of 68.0 uL/min in human hepatic microsomes, over 1000.0 uL/min in Sprague-Dawley rat hepatic microsomes, and 408.0 uL/min in CD1 mouse hepatic microsomes. It also demonstrates good metabolic stability in rat brain, with less than 3.0% of the parent compound remaining after 30 minutes..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
DPA-714 is a high-affinity translocator protein (TSPO) ligand (Ki=7 nM) designed with a fluorine atom, allowing labeling with fluorine-18 for in vivo imaging via positron emission tomography. [18F]DPA-714 successfully enables specific imaging of inflammation in various neuroinflammation models and a brain tumor model.
Targets&IC50
TSPO:(ki)7 nM
Chemical Properties
Molecular Weight398.47
FormulaC22H27FN4O2
Cas No.958233-07-3
SmilesCCN(CC)C(=O)Cc1c(nn2c(C)cc(C)nc12)-c1ccc(OCCF)cc1
Relative Density.1.18 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 41.67 mg/mL (104.57 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.02 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5096 mL12.5480 mL25.0960 mL125.4800 mL
5 mM0.5019 mL2.5096 mL5.0192 mL25.0960 mL
10 mM0.2510 mL1.2548 mL2.5096 mL12.5480 mL
20 mM0.1255 mL0.6274 mL1.2548 mL6.2740 mL
50 mM0.0502 mL0.2510 mL0.5019 mL2.5096 mL
100 mM0.0251 mL0.1255 mL0.2510 mL1.2548 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DPA-714 | purchase DPA-714 | DPA-714 cost | order DPA-714 | DPA-714 chemical structure | DPA-714 formula | DPA-714 molecular weight